Cardiovascular Systems logo
Cardiovascular Systems CSII

Quarterly report 2022-Q4
added 02-09-2023

report update icon

Cardiovascular Systems General and Administrative Expenses 2011-2025 | CSII

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.
What these expenses include
  • Salaries of administrative staff (executives, HR, accountants, legal personnel)
  • Office rent and utilities
  • Office equipment and IT infrastructure
  • Professional services (auditors, lawyers, consultants)
  • Insurance
  • General administrative travel and representation expenses
What the metric indicates
  • Cost control
    A high level of such expenses may indicate inefficient management or an overly complex structure
  • Profitability
    Reducing administrative expenses while maintaining stable revenue increases operating profit
  • Comparative analysis
    Investors can compare this metric as a percentage of revenue among companies in the same industry
  • Business flexibility
    Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Cardiovascular Systems

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
171 M 167 M 170 M - - - - - - - 66.4 M 62.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
171 M 62.4 M 127 M

Quarterly General and Administrative Expenses Cardiovascular Systems

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
41.6 M 44.5 M 86.1 M 41.7 M 40.4 M 41.9 M 82.3 M 41.4 M 40.1 M 40.3 M 40.1 M 41.4 M 46.9 M 46.8 M 46.9 M 46.8 M 41.1 M 41.2 M 41.1 M 41.2 M 37 M 35.9 M 37 M 35.9 M 34 M 36.9 M 34 M 36.9 M 41.3 M 41.4 M 41.3 M 41.4 M 32.6 M 33.5 M 32.6 M 33.5 M 27.5 M 25.4 M 27.5 M 25.4 M 20.4 M 20 M 20.4 M 20 M 15.7 M 15.4 M 15.7 M 15.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
86.1 M 15.4 M 36.8 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer General and Administrative Expenses Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
25.6 M - - $ 1.77 B usaUSA
Abiomed Abiomed
ABMD
334 M - - $ 17.2 B usaUSA
Acutus Medical Acutus Medical
AFIB
14.1 M - -26.83 % $ 2.62 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
22.2 M $ 3.79 -1.81 % $ 131 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
8.78 M - -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
814 M $ 306.68 -0.46 % $ 8.65 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
20.6 M - - $ 475 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
11.6 M - 37.08 % $ 85.7 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
894 M $ 45.79 1.46 % $ 6.82 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
7.11 M - 3.58 % $ 2.21 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
11.7 B $ 128.4 2.33 % $ 223 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
5.98 B $ 92.01 -0.6 % $ 135 B usaUSA
Conformis Conformis
CFMS
28.8 M - - $ 16.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
141 M - -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
5.9 M $ 3.16 9.55 % $ 118 M franceFrance
Cutera Cutera
CUTR
63.3 M - -10.19 % $ 1.99 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
8.46 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.88 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
8.5 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
18 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
14.7 M - - $ 111 M canadaCanada
Eargo Eargo
EAR
54.3 M - - $ 10.2 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
8.46 M - 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
98.6 M - - $ 955 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
163 M $ 9.59 -2.74 % $ 689 M israelIsrael
InMode Ltd. InMode Ltd.
INMD
8.41 M $ 14.36 -1.03 % $ 1.14 B israelIsrael
IRIDEX Corporation IRIDEX Corporation
IRIX
8.75 M $ 0.98 5.89 % $ 15.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
15.9 M $ 96.66 0.44 % $ 1.22 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
806 K - -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
1.76 B $ 163.43 -1.21 % $ 12.2 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
47.9 M $ 1.05 -0.94 % $ 108 M usaUSA
Avinger Avinger
AVGR
14.1 M - -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
12 M $ 12.55 -1.3 % $ 339 M usaUSA
FONAR Corporation FONAR Corporation
FONR
23.5 M $ 14.83 0.54 % $ 97.2 M usaUSA
AxoGen AxoGen
AXGN
39 M $ 29.82 -1.88 % $ 1.32 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
40.2 M - - $ 3.31 B usaUSA
GBS GBS
GBS
8.88 M - -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
117 M $ 40.28 -1.33 % $ 1.24 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
526 M $ 62.88 0.21 % $ 3.41 B britainBritain
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
103 M $ 17.67 0.4 % $ 408 M usaUSA
Globus Medical Globus Medical
GMED
981 M $ 86.48 -0.24 % $ 11.7 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
717 M $ 13.54 0.86 % $ 1.04 B usaUSA
LENSAR LENSAR
LNSR
26.5 M $ 11.6 0.78 % $ 134 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
14.1 M - 1.37 % $ 20.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
450 M $ 19.95 -0.08 % $ 2.85 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
3.24 M $ 3.15 -7.35 % $ 4.92 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
140 M $ 72.06 -0.63 % $ 2.03 B costa-ricaCosta-rica